MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/bph.14368

Медицинская библиотека · British journal of pharmacology · 2018

The isothiocyanate sulforaphane modulates platelet function and protects against cerebral thrombotic dysfunction.

Gillespie Scarlett, Holloway Paul M, Becker Felix, Rauzi Francesca, Vital Shantel A, Taylor Kirk A, Stokes Karen Y, Emerson Michael, Gavins Felicity N E

СтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND AND PURPOSE: Platelet activation provides a critical link between inflammation and thrombosis. Sulforaphane (SFN), a naturally occurring isothiocyanate, has been shown to display both anti-inflammatory and anti-thrombotic actions in the systemic microvasculature. As inflammation promotes thrombosis and vice versa, in this study we investigated whether SFN is able to reduce inflammatory potentiation of thrombotic events, suppress platelet activation and thrombus formation in the cerebral microvasculature.

EXPERIMENTAL APPROACH: Thrombosis was induced in the murine brain using the light/dye-injury model, in conjunction with LPS treatment, with and without SFN treatment. In vitro and in vivo platelet assays (aggregation, flow and other functional tests) were also employed, using both human and murine platelets.

KEY

RESULTS

SFN was found to reduce LPS-mediated enhancement of thrombus formation in the cerebral microcirculation. In tail-bleed experiments, LPS treatment prolonged bleeding time, and SFN treatment was found to protect against this LPS-induced derangement of platelet function. SFN inhibited collagen-mediated platelet aggregation in vitro and in vivo and the associated adhesion and impaired calcium signalling. Furthermore, glycoprotein VI was shown to be involved in the protective effects observed with SFN treatment.

CONCLUSIONS AND IMPLICATIONS: The data presented here provide evidence for the use of SFN in preventing stroke in selected high-risk patient cohorts.

Для цитирования: Gillespie Scarlett, Holloway Paul M, Becker Felix, Rauzi Francesca, Vital Shantel A, Taylor Kirk A, Stokes Karen Y, Emerson Michael, Gavins Felicity N E. The isothiocyanate sulforaphane modulates platelet function and protects against cerebral thrombotic dysfunction.. British journal of pharmacology. 2018. DOI: 10.1111/bph.14368.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.